Vitamin C Drip Therapy at RE:BERRY Myeongdong Seoul

Pharmacokinetics of Intravenous vs Oral Vitamin C

The fundamental advantage of vitamin C drip therapy lies in pharmacokinetics. Oral vitamin C is subject to saturable intestinal absorption via sodium-dependent vitamin C transporters (SVCT1), limiting plasma concentrations to approximately 220 micromol/L even at maximum oral dosing. Padayatty et al. (2004) demonstrated that intravenous administration bypasses this bottleneck entirely, achieving plasma concentrations of 13,000-15,000 micromol/L — roughly 70 times higher than the oral ceiling. These supraphysiological concentrations enable vitamin C to function as a pro-drug, generating hydrogen peroxide selectively in extracellular fluid while maintaining its role as a potent intracellular antioxidant. At RE:BERRY Myeongdong, vitamin C drip therapy protocols leverage this pharmacokinetic advantage to deliver therapeutic doses that oral supplementation simply cannot replicate.

Vitamin C and Collagen Biosynthesis

Ascorbic acid serves as an indispensable cofactor for prolyl-4-hydroxylase and lysyl hydroxylase, enzymes that hydroxylate proline and lysine residues in procollagen. Without adequate vitamin C, collagen molecules cannot form stable triple-helix structures and are rapidly degraded intracellularly. Pullar et al. (2017) published a comprehensive review documenting that vitamin C stimulates collagen gene expression in dermal fibroblasts, increases procollagen mRNA stability, and promotes fibroblast proliferation. In clinical settings, patients receiving serial high-dose IV vitamin C showed measurable improvements in skin elasticity and dermal collagen density, supporting the use of vitamin C drip therapy for anti-aging skin rejuvenation.

Melanin Inhibition and Skin Brightening Mechanisms

Vitamin C inhibits melanogenesis through multiple pathways. It directly reduces dopaquinone, an intermediate in melanin synthesis, back to DOPA, and chelates copper ions at the active site of tyrosinase. Telang (2013) reviewed the dermatological applications of vitamin C and confirmed its dual role as both a melanin synthesis inhibitor and a reducing agent that converts existing dark oxidized melanin to a lighter reduced form. When vitamin C drip therapy is combined with glutathione injection, the two antioxidants work synergistically — glutathione redirects melanin synthesis from dark eumelanin toward lighter pheomelanin, while vitamin C slows overall melanin production. This dual mechanism is why RE:BERRY Myeongdong physicians frequently prescribe combined vitamin C and glutathione protocols for patients seeking maximum skin brightening.

Safety Profile of High-Dose IV Vitamin C

High-dose intravenous vitamin C has an established safety record when administered under proper medical supervision. The primary contraindication is glucose-6-phosphate dehydrogenase (G6PD) deficiency, as supraphysiological ascorbate levels can trigger hemolytic anemia in affected individuals. Patients with renal insufficiency require dose adjustment due to the risk of oxalate nephropathy. At RE:BERRY Myeongdong, every patient undergoes medical screening before their first vitamin C drip therapy session. Outside these specific contraindications, Hoffer et al. (2008) reported that IV vitamin C doses up to 1.5 g/kg were well-tolerated in a Phase I clinical trial with no grade 3 or 4 adverse events, confirming the favorable safety margin of medically supervised vitamin C drip therapy.

Padayatty SJ et al. Ann Intern Med. 2004;140(7):533-537. doi:10.7326/0003-4819-140-7-200404060-00010

Pullar JM et al. Nutrients. 2017;9(8):866. doi:10.3390/nu9080866

Telang PS. Indian Dermatol Online J. 2013;4(2):143-146. doi:10.4103/2229-5178.110593

Hoffer LJ et al. Ann Oncol. 2008;19(11):1969-1974. doi:10.1093/annonc/mdn377